XASX
BUB
Market cap61mUSD
Oct 09, Last price
0.11AUD
1D
6.06%
1Q
31.25%
Name
Bubs Australia Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bubs Australia Limited, along with its associated entities, specializes in the manufacturing and global distribution of a diverse range of infant nutrition products, catering to consumers in Australia, China, and other international markets. Operating under its primary 'Bubs' brand, the company's offerings span organic baby foods, goat milk and organic cow's milk formulas (including infant and supreme variants), adult goat milk powder, and fresh dairy items. The product portfolio further extends to convenient pouches, wholesome cereals and porridges, rusks, and various snacks. Beyond its core brands, Bubs Australia also provides children's vitamin and mineral supplements, branded as 'Vita Bubs'. It additionally offers specialized canning services for nutritional dairy goods and safeguards its proprietary intellectual property and trademarks. The company, established in 1993, has its principal office situated in Frenchs Forest, Australia.
Key people
Naomi Verloop
Chief Financial Officer · since 2025
Richard Paine
Chief Operating Officer · since 2023
Peter Cope
General Counsel, Company Secretary · since 2025
Olga Smejkalova
Company Secretary · since 2025
Joe Coote
Chief Executive Officer, Managing Director, Director · since 2025
Director · since 2025
Steve Lin
Non-Executive Director · since 2019
Paul Jensen
Independent Non-Executive Director · since 2023
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||